Journal of Reproductive Immunology
Volume 85, Issue 1 , Pages 93-98 , May 2010

Human chorionic gonadotropin: A hormone with immunological and angiogenic properties

  • Marie Tsampalas

      Affiliations

    • University of Liege, Centre of Immunology, CHU B-23, B-4000 Liege, Belgium
    • ,
  • Virginie Gridelet

      Affiliations

    • University of Liege, Centre of Immunology, CHU B-23, B-4000 Liege, Belgium
    • ,
  • Sarah Berndt

      Affiliations

    • University of Liege, Laboratory of tumour and development biology, CHU B-23, B-4000 Liege, Belgium
    • ,
  • Jean-Michel Foidart

      Affiliations

    • University of Liege, Laboratory of tumour and development biology, CHU B-23, B-4000 Liege, Belgium
    • University of Liege, Department of Gynaecology and Obstetrics, Centre of AMP, CHR Citadelle, B-4000 Liege, Belgium
    • ,
  • Vincent Geenen

      Affiliations

    • University of Liege, Centre of Immunology, CHU B-23, B-4000 Liege, Belgium
    • ,
  • Sophie Perrier d’Hauterive

      Affiliations

    • University of Liege, Centre of Immunology, CHU B-23, B-4000 Liege, Belgium
    • University of Liege, Department of Gynaecology and Obstetrics, Centre of AMP, CHR Citadelle, B-4000 Liege, Belgium
    • Corresponding Author InformationCorresponding author at: University of Liege, Department of Gynaecology and Obstetrics, Centre of AMP, CHR de la Citadelle, Bld du 12ème de Ligne, B-4000 Liege, Belgium. Tel.: +32 4 225 71 63; fax: +32 4 225 66 57.

Received 30 August 2009 ,Revised 22 November 2009 ,Accepted 25 November 2009.

References 

  1. Ascoli M, Segaloff DL. On the structure of the luteinizing hormone/chorionic gonadotropin receptor. Endocr. Rev. 1989;10:27–44
  2. Berndt S, Blacher S, Perrier d’Hauterive S, Thiry M, Tsampalas M, Cruz A, et al. Chorionic gonadotropin stimulation of angiogenesis and pericyte recruitment. J. Clin. Endocrinol. Metab. 2009;94(11):4567–4574Epub 2009 Oct 16
  3. Berndt S, Perrier d’Hauterive S, Blacher S, Pequeux C, Lorquet S, Munaut C, et al. Angiogenic activity of human chorionic gonadotropin through LH receptor activation on endothelial and epithelial cells of the endometrium. FASEB J. 2006;20:2630–2632
  4. Bonduelle ML, Dodd R, Liebaers I, Van Steirteghem A, Williamson R, Akhurst R. Chorionic gonadotrophin-beta mRNA, a trophoblast marker, is expressed in human 8-cell embryos derived from tripronucleate zygotes. Hum. Reprod. 1988;3:909–914
  5. Challis JR, Lockwood CJ, Myatt L, Norman JE, Strauss JF, Petraglia F. Inflammation and pregnancy. Reprod. Sci. 2009;16:206–215
  6. Cole LA. New discoveries on the biology and detection of human chorionic gonadotropin. Reprod. Biol. Endocrinol. 2009;7:8
  7. Dong M, Ding G, Zhou J, Wang H, Zhao Y, Huang H. The effect of trophoblasts on T lymphocytes: possible regulatory effector molecules—a proteomic analysis. Cell Physiol. Biochem. 2008;21:463–472
  8. Dufau ML. The luteinizing hormone receptor. Annu. Rev. Physiol. 1998;60:461–496
  9. Fazleabas AT, Kim JJ, Strakova Z. Implantation: embryonic signals and the modulation of the uterine environment—a review. Placenta. 2004;25(Suppl. A):S26–31
  10. Fluhr H, Bischof-Islami D, Krenzer S, Licht P, Bischof P, Zygmunt M. Human chorionic gonadotropin stimulates matrix metalloproteinases-2 and -9 in cytotrophoblastic cells and decreases tissue inhibitor of metalloproteinases-1, -2, and -3 in decidualized endometrial stromal cells. Fertil. Steril. 2008;90:1390–1395
  11. Fluhr H, Carli S, Deperschmidt M, Wallwiener D, Zygmunt M, Licht P. Differential effects of human chorionic gonadotropin and decidualization on insulin-like growth factors-I and -II in human endometrial stromal cells. Fertil. Steril. 2008;90:1384–1389
  12. Fraccaroli L, Alfieri J, Leiros CP, Ramhorst R. Immunomodulatory effects of chemokines during the early implantation window. Front. Biosci. (Elite Ed.). 2009;1:288–298
  13. Gutman G, Barak V, Maslovitz S, Amit A, Lessing JB, Geva E. Regulation of vascular endothelial growth factor-A and its soluble receptor sFlt-1 by luteinizing hormone in vivo: implication for ovarian follicle angiogenesis. Fertil. Steril. 2008;89:922–926
  14. Herr F, Baal N, Reisinger K, Lorenz A, McKinnon T, Preissner KT, et al. HCG in the regulation of placental angiogenesis. Results of an in vitro study. Placenta. 2007;28(Suppl. A):S85–S93
  15. Horiuchi A, Nikaido T, Yoshizawa T, Itoh K, Kobayashi Y, Toki T, et al. HCG promotes proliferation of uterine leiomyomal cells more strongly than that of myometrial smooth muscle cells in vitro. Mol. Hum. Reprod. 2000;6:523–528
  16. Hoshina M, Boothby M, Hussa R, Pattillo R, Camel HM, Boime I. Linkage of human chorionic gonadotrophin and placental lactogen biosynthesis to trophoblast differentiation and tumorigenesis. Placenta. 1985;6:163–172
  17. Jurisicova A, Antenos M, Kapasi K, Meriano J, Casper RF. Variability in the expression of trophectodermal markers beta-human chorionic gonadotrophin, human leukocyte antigen-G and pregnancy specific beta-1 glycoprotein by the human blastocyst. Hum. Reprod. 1999;14:1852–1858
  18. Kalkunte S, Chichester CO, Gotsch F, Sentman CL, Romero R, Sharma S. Evolution of non-cytotoxic uterine natural killer cells. Am. J. Reprod. Immunol. 2008;59:425–432
  19. Kane N, Kelly R, Saunders PT, Critchley HO. Proliferation of uterine natural killer cells is induced by human chorionic gonadotropin and mediated via the mannose receptor. Endocrinology. 2009;150:2882–2888
  20. Kayisli UA, Selam B, Guzeloglu-Kayisli O, Demir R, Arici A. Human chorionic gonadotropin contributes to maternal immunotolerance and endometrial apoptosis by regulating Fas-Fas ligand system. J. Immunol. 2003;171:2305–2313
  21. Keay SD, Vatish M, Karteris E, Hillhouse EW, Randeva HS. The role of hCG in reproductive medicine. BJOG. 2004;111:1218–1228
  22. Khan NA, Khan A, Savelkoul HF, Benner R. Inhibition of diabetes in NOD mice by human pregnancy factor. Hum. Immunol. 2001;62:1315–1323
  23. Kornyei JL, Lei ZM, Rao CV. Human myometrial smooth muscle cells are novel targets of direct regulation by human chorionic gonadotropin. Biol. Reprod. 1993;49:1149–1157
  24. Kosaka K, Fujiwara H, Tatsumi K, Yoshioka S, Sato Y, Egawa H, et al. Human chorionic gonadotropin (HCG) activates monocytes to produce interleukin-8 via a different pathway from luteinizing hormone/HCG receptor system. J. Clin. Endocrinol. Metab. 2002;87:5199–5208
  25. Lee TK, Kim DI, Song YL, Lee YC, Kim HM, Kim CH. Differential inhibition of Scutellaria barbata D. Don (Lamiaceae) on HCG-promoted proliferation of cultured uterine leiomyomal and myometrial smooth muscle cells. Immunopharmacol. Immunotoxicol. 2004;26:329–342
  26. Licht P, Losch A, Dittrich R, Neuwinger J, Siebzehnrubl E, Wildt L. Novel insights into human endometrial paracrinology and embryo-maternal communication by intrauterine microdialysis. Hum. Reprod. Update. 1998;4:532–538
  27. Lopata A, Hay DL. The potential of early human embryos to form blastocysts, hatch from their zona and secrete HCG in culture. Hum. Reprod. 1989;4:87–94
  28. Minas V, Loutradis D, Makrigiannakis A. Factors controlling blastocyst implantation. Reprod. Biomed. Online. 2005;10:205–216
  29. Moffett A, Loke C. Immunology of placentation in eutherian mammals. Nat. Rev. Immunol. 2006;6:584–594
  30. Perrier d’Hauterive S. Implantation: the first maternal–embryo crosstalk. J. Gynecol. Obstet. Biol. Reprod. (Paris). 2004;33:S5–8
  31. Perrier d’Hauterive S, Charlet-Renard C, Berndt S, Dubois M, Munaut C, Goffin F, et al. Human chorionic gonadotropin and growth factors at the embryonic-endometrial interface control leukemia inhibitory factor (LIF) and interleukin 6 (IL-6) secretion by human endometrial epithelium. Hum. Reprod. 2004;19:2633–2643
  32. Perrier d’Hauterive S, Charlet-Renard C, Dubois M, Berndt S, Goffin F, Foidart JM, et al. Human endometrial leukemia inhibitory factor and interleukin-6: control of secretion by transforming growth factor-beta-related members. Neuroimmunomodulation. 2005;12:157–163
  33. Policastro PF, Daniels-McQueen S, Carle G, Boime I. A map of the hCG beta-LH beta gene cluster. J. Biol. Chem. 1986;261:5907–5916
  34. Psychoyos A. Uterine receptivity for nidation. Ann. N.Y. Acad. Sci. 1986;476:36–42
  35. Puett D, Li Y, DeMars G, Angelova K, Fanelli F. A functional transmembrane complex: the luteinizing hormone receptor with bound ligand and G protein. Mol. Cell Endocrinol. 2007;260–262:126–136
  36. Reisinger K, Baal N, McKinnon T, Munstedt K, Zygmunt M. The gonadotropins: tissue-specific angiogenic factors?. Mol. Cell Endocrinol. 2007;269:65–80
  37. Reshef E, Lei ZM, Rao CV, Pridham DD, Chegini N, Luborsky JL. The presence of gonadotropin receptors in nonpregnant human uterus, human placenta, fetal membranes, and decidua. J. Clin. Endocrinol. Metab. 1990;70:421–430
  38. Schumacher A, Brachwitz N, Sohr S, Engeland K, Langwisch S, Dolaptchieva M, et al. Human chorionic gonadotropin attracts regulatory T cells into the fetal–maternal interface during early human pregnancy. J. Immunol. 2009;182:5488–5497
  39. Sherwin JR, Sharkey AM, Cameo P, Mavrogianis PM, Catalano RD, Edassery S, et al. Identification of novel genes regulated by chorionic gonadotropin in baboon endometrium during the window of implantation. Endocrinology. 2007;148:618–626
  40. Simpson DZ, Hitchen PG, Elmhirst EL, Taylor ME. Multiple interactions between pituitary hormones and the mannose receptor. Biochem. J. 1999;343(Pt 2):403–411
  41. Srisuparp S, Strakova Z, Brudney A, Mukherjee S, Reierstad S, Hunzicker-Dunn M, et al. Signal transduction pathways activated by chorionic gonadotropin in the primate endometrial epithelial cells. Biol. Reprod. 2003;68:457–464
  42. Sugihara K, Kabir-Salmani M, Byrne J, Wolf DP, Lessey B, Iwashita M, et al. Induction of trophinin in human endometrial surface epithelia by CGbeta and IL-1beta. FEBS Lett. 2008;582:197–202
  43. Ticconi C, Zicari A, Belmonte A, Realacci M, Rao Ch V, Piccione E. Pregnancy-promoting actions of HCG in human myometrium and fetal membranes. Placenta. 2007;28(Suppl. A):S137–143
  44. Torry DS, Leavenworth J, Chang M, Maheshwari V, Groesch K, Ball ER, et al. Angiogenesis in implantation. J. Assist. Reprod. Genet. 2007;24:303–315
  45. Toth P, Li X, Rao CV, Lincoln SR, Sanfilippo JS, Spinnato JA, et al. Expression of functional human chorionic gonadotropin/human luteinizing hormone receptor gene in human uterine arteries. J. Clin. Endocrinol. Metab. 1994;79:307–315
  46. Toth P, Lukacs H, Gimes G, Sebestyen A, Pasztor N, Paulin F, et al. Clinical importance of vascular LH/hCG receptors—a review. Reprod. Biol. 2001;1:5–11
  47. Ueno A, Cho S, Cheng L, Wang J, Hou S, Nakano H, et al. Transient upregulation of indoleamine 2,3-dioxygenase in dendritic cells by human chorionic gonadotropin downregulates autoimmune diabetes. Diabetes. 2007;56:1686–1693
  48. Wan H, Versnel MA, Cheung WY, Leenen PJ, Khan NA, Benner R, et al. Chorionic gonadotropin can enhance innate immunity by stimulating macrophage function. J. Leukoc. Biol. 2007;82:926–933
  49. Wan H, Versnel MA, Leijten LM, van Helden-Meeuwsen CG, Fekkes D, Leenen PJ, et al. Chorionic gonadotropin induces dendritic cells to express a tolerogenic phenotype. J. Leukoc. Biol. 2008;83:894–901
  50. Zenclussen AC, Gerlof K, Zenclussen ML, Ritschel S, Zambon Bertoja A, Fest S, et al. Regulatory T cells induce a privileged tolerant microenvironment at the fetal–maternal interface. Eur. J. Immunol. 2006;36:82–94
  51. Zygmunt M, Herr F, Keller-Schoenwetter S, Kunzi-Rapp K, Munstedt K, Rao CV, et al. Characterization of human chorionic gonadotropin as a novel angiogenic factor. J. Clin. Endocrinol. Metab. 2002;87:5290–5296

PII: S0165-0378(10)00035-5

doi: 10.1016/j.jri.2009.11.008

Journal of Reproductive Immunology
Volume 85, Issue 1 , Pages 93-98 , May 2010

Article Tools